Canada: Ontario Proposes Regulation Under "Sunshine" Law

Ontario is currently seeking feedback on its newly released proposed regulation under the "sunshine" legislation, the Health Sector Payment Transparency Act, 2017 (HSPTA). The proposed regulation was released on February 21. The HSPTA was enacted on December 12, 2017.1

What You Need To Know

  • The new legislation will require the medical product industry (payor), including both drug manufacturers and medical device companies, to report annually on payments (transfer of value) made to individuals and organizations in the health care sector (recipients).
  • The definition of transfer of value is very broad, and would cover fees and payments made under agreements that are common in the industry.
  • The coming into force date is expected to be January 1, 2019.
  • Feedback on the proposed regulation is being sought until April 6.2

Details of the Proposed Legislation

The key aspects of the regulatory proposal include the following:

Payors. Payors are defined to include companies that manufacture, import, promote and sell medical products (drugs or medical devices), and organizers of continuing education events for health care professionals. The proposed regulation adds pharmacies and laboratory/specimen collection centres as payors regulated under the HSPTA.

We note that draft regulation proposes to exclude recreational cannabis from the definition of a drug, but the regulatory framework would apply to medical cannabis. Thus, the HSPTA would not apply to producers and distributors of recreational cannabis once it is legalized, but would apply to producers and distributors of medical cannabis.

Further, those who facilitate a transfer of value (intermediaries) would also be regulated under the HSPTA, regardless of whether the payor directs how the transfer of value is to be made, or is aware of the recipients' identities. The exception to being considered an intermediary is narrow.

Recipients. The proposed regulation includes an extensive list of individuals/organizations that would be considered recipients under the HSPTA. Other than the obvious candidates, such as health care professionals, health regulatory colleges, hospitals and other health care facilities, the list also includes pharmacies, laboratory/specimen collection centres, advocacy organizations (for health care professionals or patient groups), health charities, group purchasing organizations, universities and research institutions, and subsidiaries of the specified organizations. The proposal would capture board members, directors/officers, employees of the specified organizations, as well as immediate family members of the above individuals.

Transfer of value. The proposed regulation would specify the transfer of value that must be reported by a payor to include cash, in-kind items/services, investment interests, as well as compensation for services, honoraria, grants/donations/sponsorship, membership fees, and rental/facility fees. Compensation for services would seemingly include fee for service agreements and thus be caught by the proposed regulation. Contracts with key opinion leaders would seemingly be included and thus also be caught. A transfer of value would also include rebates/discounts, items provided on a value-added basis in procurements, inventory listing fees, equipment/leases of equipment longer than 90 days, licensing/copyright fees, royalties, referral fees, marketing fees, and renovations. Unsurprisingly, any personal gifts, entertainment, travel and accommodations provided would be considered a transfer of value. The proposal would exclude the fair market value of goods that a payor sells to a recipient.

Exemptions. The proposed regulation would exempt a number of transactions from the reporting requirement. These transactions include employment salary/benefits, medical products intended to be given to patients for free, educational materials intended for use within a clinical setting, and compensation for expert testimony/services in a legal proceeding. In addition, the proposed regulation would exempt prompt payment, volume discounts and distribution service fees provided by drug manufacturers as prescribed under legislation.3

Threshold, manner and frequency of report. The draft regulation proposes the dollar value threshold to reporting to be $10. The payors would report the transfer of values through an online platform by June 30 each year. The first reporting would be required by June 30, 2020.

Penalties. As reported in our prior bulletin,4 the HSPTA sets out the penalties for non-compliance. Persons who contravene the HSPTA or its regulations may be subject to a fine of the following amount for each day or part day the offence occurs or continues:

  • an individual's first offence: fine not exceeding $10,000;
  • an individual's subsequent offence: not exceeding $25,000;
  • a corporation's first offence: not exceeding $50,000; and
  • a corporation's subsequent offence: not exceeding $100,000.

What's Next

Although enacted into law, the HSPTA has not yet been proclaimed into force. The province proposes to set January 1, 2019 as the coming into force date for the HSPTA and its regulation. The proposed regulation intends to clarify important details surrounding the implementation of HSPTA. As noted, the government is seeking feedback on the proposed regulation under the HSPTA and interested parties are encouraged to submit comments by April 6.

Ontario is the first province to mandate private sector payments to the health care sector. As the first reporting period due date is currently contemplated as June 30, 2020, medical product companies should take the opportunity to review current agreements and arrangements with health care professionals and organizations to prepare for implementation of this legislation. Other Canadian provinces are likely watching developments in Ontario closely but so far have not proceeded to enact similar regulations.


1 See: The final version of the passed legislation remained largely unchanged from the initial draft. We have previously published on the proposed HSPTA, see, " More Transparency in Health Care: Ontario's Proposed "Sunshine" Legislation."

2 See:

3 Ordinary commercial terms that are permissible under the Ontario Drug Benefit Act /Ontario Regulation 201/96 (General) would not be reported.

4 See " More Transparency in Health Care: Ontario's Proposed "Sunshine" Legislation."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions